Drug Discovery and Chemical Biology

The Drug Discovery and Chemical Biology (DDCB) Consortium is a Biocenter Finland -funded national research infrastructure for academic researchers in Finland.

DDCB coordinates infrastructure and expertise in the areas of drug discovery and chemical biology, and makes it available to the scientific community. It is formed by Institute for Molecular Medicine Finland, FIMM (University of Helsinki, UH), Biocenter Kuopio (University of Eastern Finland, UEF), Faculty of Pharmacy at the University of Helsinki, BioCity Turku (University of Turku and Åbo Academy University) and CSC – IT Center for Science. The principal investigator of the DDCB consortium is Professor Päivi Tammela (UH).

DDCB services are used by 134 research groups, of which 9 were non-academic. Several new technologies have been utilized, and DDCB has participated actively in European activities such as EU-OPENSCREEN.